A detailed history of Franklin Resources Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 17,693,268 shares of MRK stock, worth $2.22 Billion. This represents 0.77% of its overall portfolio holdings.

Number of Shares
17,693,268
Previous 10,114,295 74.93%
Holding current value
$2.22 Billion
Previous $1.1 Billion 111.73%
% of portfolio
0.77%
Previous 0.53%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $858 Million - $1 Billion
7,578,973 Added 74.93%
17,693,268 $2.33 Billion
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $61.8 Million - $67.3 Million
617,022 Added 6.5%
10,114,295 $1.1 Billion
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $263 Million - $292 Million
2,556,466 Added 36.83%
9,497,273 $978 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $91.3 Million - $99.5 Million
840,657 Added 13.78%
6,940,807 $801 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $12.7 Million - $14.2 Million
-123,532 Reduced 1.98%
6,100,150 $649 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $373 Million - $478 Million
-4,263,655 Reduced 40.66%
6,223,682 $690 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $84.4 Million - $94.8 Million
-998,050 Reduced 8.69%
10,487,337 $903 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $562 Million - $637 Million
-6,727,813 Reduced 36.94%
11,485,387 $1.05 Billion
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $1.16 Billion - $1.31 Billion
-15,845,328 Reduced 46.52%
18,213,200 $1.49 Billion
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $376 Million - $471 Million
-5,203,831 Reduced 13.25%
34,058,528 $2.61 Billion
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $32.8 Million - $36.1 Million
457,650 Added 1.18%
39,262,359 $2.95 Billion
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $235 Million - $260 Million
3,348,929 Added 9.45%
38,804,709 $3.02 Billion
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $418 Million - $492 Million
6,063,098 Added 20.63%
35,455,780 $2.73 Billion
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $298 Million - $330 Million
4,147,525 Added 16.43%
29,392,682 $2.4 Billion
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $144 Million - $163 Million
1,961,123 Added 8.42%
25,245,157 $2.09 Billion
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $367 Million - $417 Million
5,206,332 Added 28.8%
23,284,034 $1.83 Billion
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $59.2 Million - $82 Million
933,775 Added 5.45%
18,077,702 $1.39 Billion
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $182 Million - $205 Million
-2,342,902 Reduced 12.02%
17,143,927 $1.56 Billion
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $34.1 Million - $37.2 Million
-448,372 Reduced 2.25%
19,486,829 $1.64 Billion
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $444 Million - $518 Million
-6,352,133 Reduced 24.16%
19,935,201 $1.67 Billion
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $192 Million - $219 Million
-2,762,634 Reduced 9.51%
26,287,334 $2.19 Billion
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $734 Million - $852 Million
-11,257,974 Reduced 27.93%
29,049,968 $2.22 Billion
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $273 Million - $321 Million
-4,735,134 Reduced 10.51%
40,307,942 $2.86 Billion
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $206 Million - $242 Million
-4,058,538 Reduced 8.27%
45,043,076 $2.73 Billion
Q1 2018

May 10, 2018

BUY
$50.96 - $59.23 $300 Million - $348 Million
5,880,457 Added 13.61%
49,101,614 $2.67 Billion
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $822 Million - $982 Million
15,932,771 Added 58.39%
43,221,157 $2.43 Billion
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $1.6 Billion - $1.72 Billion
27,288,386
27,288,386 $1.75 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $318B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.